Trump, officials link Tylenol to autism as medical community balks
Senate Health, Education, Labor and Pensions Chair Bill Cassidy, R-La., called the link between Tylenol and autism "bogus" during a Sept. 6 interview.
Search Roll Call
Search the Roll Call archive by keyword, date, Congress, section, or tags.
46 results for "6"
Kennedy’s vaccine advisory panel upends shot recommendations
The CDC’s Advisory Committee on Immunization Practices, often known as ACIP, voted 12-0 to recommend that all people ages 65 and older and people ages 6 months to 64 with underlying conditions receive
Kennedy’s mental health drug skepticism lands at FDA panel
Roughly 6 percent of pregnant women will take an SSRI at some point during pregnancy.
Panel recommends removing thimerosal from flu vaccines
The committee also voted 6-0, with Pebsworth abstaining, to reaffirm the panel’s recommendation that people 6 months or older who don’t have "contraindications" receive a routine annual influenza vaccination
FDA won’t approve COVID shot for healthy, non-elderly population
The CDC currently recommends COVID-19 shots for anyone age 6 months or older.
As Sweden regulates nicotine products, US pulls back
It’s not standardized, meaning brands use different baseline systems for levels 4, 5 or 6. The industry standard is to not sell products with more than 20 milligrams of nicotine.Â
Targeting FDA user fees would leave agency gutted, experts say
Dr. Marty Makary, nominee to be commissioner of the FDA, appears before the Senate Health, Education, Labor and Pensions Committee for his confirmation hearing in the Dirksen Senate Office Building in Washington on March 6.
Senate confirms Makary for FDA commissioner
"I have not been involved in any of the decisions regarding any of the personnel changes recently, but if confirmed, you have my commitment that I’ll do an assessment," he said during his March 6 appearance
Oz’s ties to insurers may loom over his CMS confirmation hearing
Mehmet Oz, President Donald Trump’s pick to lead the Centers for Medicare and Medicaid Services, speaks during a meeting with business leaders at Washington Crossing Inn in Washington Crossing, Pa., on Nov. 6, 2022. Oz ran against Sen. John Fetterman for a Pennsylvania Senate seat.
FDA authorizes first nicotine pouches
The 20 pouch types include two nicotine strengths of 3 and 6 milligrams and 10 flavors.
FDA publishes long-awaited front-of-package labeling proposal
"Maybe we need to talk about school lunch programs instead of putting all our 6-year-olds on Ozempic as the American Academy of Pediatrics has suggested."
FDA greenlights updated COVID shots, prepares for fall rollout
Both Pfizer’s and Moderna’s updated vaccines are granted full approval for people age 12 and older, and they’re authorized for emergency use for children 6 months to 11 years old.
Summer COVID surge isn’t cause for alarm, experts say
The KP.3 and KP.2 variants, both sublineages of omicron, make up a total of 61.3 percent of new cases in the two-week period ending July 6, according to the most recent data from the Centers for Disease
Growing teen THC use could further complicate cannabis policy
And states that did not regulate Delta-8 saw 14 percent reporting use compared to 6 percent in states that did regulate the substance.
Critical spending decisions await Tuesday White House meeting
In a Feb. 6 letter to congressional leaders, those organizations argued that the restrictions would deprive recipients of free choice in food and create a costly burden on retailers to enforce the restriction
Supreme Court to weigh cases on guns, regulations and redistricting in new term
high-profile cases the justices will consider and decide before the end of June are follow-ups on the court’s politically controversial major decisions in the past two terms, when conservatives had a 6-
FDA greenlights new COVID-19 shots for this fall
The agency granted emergency authorizations for use in children between 6 months and 11 years old.
FDA grants full approval to new Alzheimer’s drug
The widely expected decision follows a unanimous 6–0 recommendation from FDA’s external advisory committee in May, and signals a new era in Alzheimer’s research and treatment.
CDC data amplifies calls for funding hepatitis plan
Despite the availability of these cures, commercial data showed only 1 in 6 uninsured adults under 40 with hepatitis C has been cured, according to a Morbidity and Mortality Report published Thursday examining
Policy · 117th Congress
House report questions FDA’s approval of Alzheimer’s drug
A decision on accelerated approval is due by Jan. 6, and the company is simultaneously submitting data for full approval based on results from a Phase 3 trial.